Study to Evaluate the Safety and Tolerability of Andecaliximab as Monotherapy and in Combination With Anti-Cancer Agents in Japanese Participants With Gastric or Gastroesophageal Junction Adenocarcinoma
Clinical trial NCT02862535 · TERMINATED
Trial details
- NCT number
- NCT02862535
- Sponsor
- Gilead Sciences
- Status
- TERMINATED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2016-09-20
- Primary completion
- 2019-10-25
- Enrollment
- 36
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.